Literature DB >> 25686004

Photoaffinity labeling in target- and binding-site identification.

Ewan Smith1, Ian Collins.   

Abstract

Photoaffinity labeling (PAL) using a chemical probe to covalently bind its target in response to activation by light has become a frequently used tool in drug discovery for identifying new drug targets and molecular interactions, and for probing the location and structure of binding sites. Methods to identify the specific target proteins of hit molecules from phenotypic screens are highly valuable in early drug discovery. In this review, we summarize the principles of PAL including probe design and experimental techniques for in vitro and live cell investigations. We emphasize the need to optimize and validate probes and highlight examples of the successful application of PAL across multiple disease areas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25686004      PMCID: PMC4413435          DOI: 10.4155/fmc.14.152

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  75 in total

1.  Isotope-coded, fluorous photoaffinity labeling reagents.

Authors:  Zhiquan Song; Weigang Huang; Qisheng Zhang
Journal:  Chem Commun (Camb)       Date:  2012-02-24       Impact factor: 6.222

Review 2.  Pharmacological activities of natural triterpenoids and their therapeutic implications.

Authors:  Petr Dzubak; Marian Hajduch; David Vydra; Alica Hustova; Miroslav Kvasnica; David Biedermann; Lenka Markova; Milan Urban; Jan Sarek
Journal:  Nat Prod Rep       Date:  2006-05-03       Impact factor: 13.423

3.  Vorinostat.

Authors:  Steven Grant; Chris Easley; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2007-01       Impact factor: 84.694

Review 4.  Chemical genetics-based target identification in drug discovery.

Authors:  Feng Cong; Atwood K Cheung; Shih-Min A Huang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-08-02       Impact factor: 13.820

Review 5.  Aliphatic diazirines as photoaffinity probes for proteins: recent developments.

Authors:  Joydip Das
Journal:  Chem Rev       Date:  2011-04-05       Impact factor: 60.622

6.  Interaction of barbiturate analogs with the Torpedo californica nicotinic acetylcholine receptor ion channel.

Authors:  H R Arias; E A McCardy; M J Gallagher; M P Blanton
Journal:  Mol Pharmacol       Date:  2001-09       Impact factor: 4.436

7.  A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

Authors:  V M Richon; S Emiliani; E Verdin; Y Webb; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 8.  Principles of early drug discovery.

Authors:  J P Hughes; S Rees; S B Kalindjian; K L Philpott
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

9.  Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Authors:  Yoshihiko Kotake; Koji Sagane; Takashi Owa; Yuko Mimori-Kiyosue; Hajime Shimizu; Mai Uesugi; Yasushi Ishihama; Masao Iwata; Yoshiharu Mizui
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

10.  Chemoproteomic profiling of lysine acetyltransferases highlights an expanded landscape of catalytic acetylation.

Authors:  David C Montgomery; Alexander W Sorum; Jordan L Meier
Journal:  J Am Chem Soc       Date:  2014-05-30       Impact factor: 15.419

View more
  60 in total

1.  Small molecule target identification using photo-affinity chromatography.

Authors:  Seung-Yong Seo; Timothy W Corson
Journal:  Methods Enzymol       Date:  2019-03-15       Impact factor: 1.600

Review 2.  Advances in targeting 'undruggable' transcription factors with small molecules.

Authors:  Matthew J Henley; Angela N Koehler
Journal:  Nat Rev Drug Discov       Date:  2021-05-18       Impact factor: 84.694

3.  Importance of a 4-Alkyl Substituent for Activity in the Englerin Series.

Authors:  Daniel C Elliott; John A Beutler; Kathlyn A Parker
Journal:  ACS Med Chem Lett       Date:  2017-06-06       Impact factor: 4.345

4.  Clickable photoaffinity ligands for the human serotonin transporter based on the selective serotonin reuptake inhibitor (S)-citalopram.

Authors:  Nageswari Yarravarapu; Laura Geffert; Christopher K Surratt; Michael Cascio; David J Lapinsky
Journal:  Bioorg Med Chem Lett       Date:  2018-09-22       Impact factor: 2.823

Review 5.  Achieving Controlled Biomolecule-Biomaterial Conjugation.

Authors:  Christopher D Spicer; E Thomas Pashuck; Molly M Stevens
Journal:  Chem Rev       Date:  2018-07-24       Impact factor: 60.622

Review 6.  Developments of bioorthogonal handle-containing photo-crosslinkers for photoaffinity labeling.

Authors:  Haijun Guo; Zhengqiu Li
Journal:  Medchemcomm       Date:  2017-06-14       Impact factor: 3.597

7.  Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling.

Authors:  Sarah A Head; Jun O Liu
Journal:  J Vis Exp       Date:  2016-09-20       Impact factor: 1.355

8.  Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids.

Authors:  Bit Lee; Wei Sun; Hyungjun Lee; Halesha Basavarajappa; Rania S Sulaiman; Kamakshi Sishtla; Xiang Fei; Timothy W Corson; Seung-Yong Seo
Journal:  Bioorg Med Chem Lett       Date:  2016-07-21       Impact factor: 2.823

Review 9.  γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase.

Authors:  Pengju Nie; Abhishek Vartak; Yue-Ming Li
Journal:  Semin Cell Dev Biol       Date:  2020-04-02       Impact factor: 7.727

10.  Development of a Photo-Cross-Linkable Diaminoquinazoline Inhibitor for Target Identification in Plasmodium falciparum.

Authors:  Alexandra S Lubin; Ainoa Rueda-Zubiaurre; Holly Matthews; Hella Baumann; Fabio R Fisher; Julia Morales-Sanfrutos; Kate S Hadavizadeh; Flore Nardella; Edward W Tate; Jake Baum; Artur Scherf; Matthew J Fuchter
Journal:  ACS Infect Dis       Date:  2018-02-05       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.